2026 Annual Public Meeting of the Board of Directors
Each year, the Reagan-Udall Foundation for the FDA’s Board of Directors conducts an annual public meeting to highlight the Foundation’s activities in support of the U.S. Food and Drug Administration.
The meeting provides an opportunity for engagement among the Foundation’s Board of Directors, FDA, and external stakeholders, including patients and consumer advocates, regulated industry, health care providers, academics, and others dedicated to improving America’s health.
This year’s meeting will include updates on the Foundation’s work, reflections on current priorities in regulatory science and public health, and a discussion with FDA leadership, including Deputy Commissioner for Operations and Chief Operating Officer Melanie Keller. We'll hear updates from our Board Chair, Adrian F. Hernandez, MD, and our CEO, Susan C. Winckler, RPh, Esq., plus hold a moderated conversation reflecting on the Foundation’s impact with some of our Board members including Esther Krofah, MPP and Phuong Khanh (PK) Morrow, MD.
This is a hybrid event with options to attend virtually or in person at the Foundation's rooftop conference center at 1333 New Hampshire Ave. NW, Washington, DC. In-person seating is limited.
